About: Next generation of immunotherapy for melanoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Next generation of immunotherapy for melanoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on July 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в липні 2008 (uk) مقالة علمية نشرت في يوليو 2008 (ar) scientific article published on July 2008 (en)
publication date	wds:Q37210833-2070265E-C45F-49D8-B8AD-E394CE320F21
publication date	2008-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37210833-A7F4305A-2266-44A8-9549-F244F4273C7C
language of work or name	English
cites work	wds:Q37210833-8680A1EB-29DE-40F7-BCE3-98CF602A55C8 wds:Q37210833-D4C4E0C9-D0F0-4D85-BD2C-FB9054DE10E4 wds:Q37210833-DEC243E1-2D8F-4588-888E-352B08992104
cites work	Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stage III or stage IV malignant melanoma Kinetics of response to ipilimumab (MDX-010) in patients with stage III/IV melanoma
author name string	wds:Q37210833-195C5263-9496-42C5-BF2B-E4FAD1927AB9 wds:Q37210833-3039C1E0-A220-4759-A1CB-79135602884C wds:Q37210833-48973792-9468-4C87-9540-E5FAAA6BDD39 wds:Q37210833-50456377-2ED7-479B-84CD-88E45C032137 wds:Q37210833-51689917-B755-4A1A-841D-D3665359C357 wds:Q37210833-64EB4930-68E8-46F5-9DFE-38D5636EA957 wds:Q37210833-E1CD14AA-68B9-48D7-A039-1BFDBEF13D24
author name string	Ahmad A Tarhini Stergios J Moschos John M Kirkwood Lisa H Butterfield Hassane M Zarour Monica C Panelli Helen J Gogas
rdfs:label	Next generation of immunotherapy for melanoma (en) Next generation of immunotherapy for melanoma (nl) Next generation of immunotherapy for melanoma (ast)
skos:prefLabel	Next generation of immunotherapy for melanoma (en) Next generation of immunotherapy for melanoma (nl) Next generation of immunotherapy for melanoma (ast)
name	Next generation of immunotherapy for melanoma (en) Next generation of immunotherapy for melanoma (nl) Next generation of immunotherapy for melanoma (ast)
title	wds:Q37210833-7EC6A37F-A277-4E4A-B6EC-F4CB17A9AD9B
title	Next generation of immunotherapy for melanoma (en)
page(s)	wds:Q37210833-B1E747AB-2E06-4DE5-A8EB-219FA989FDA4
page(s)	3445-3455
instance of	wds:Q37210833-719f6136-6e60-47b8-9fd9-d54a123c2ab4 wds:Q37210833-FBA13751-4657-4EA0-99A5-8E5B7DF9F50C
instance of	review article scholarly article
main subject	wds:Q37210833-CCD41749-60C9-4664-8295-4A8CA7BFD8D7
main subject	immunotherapy
PubMed ID	wds:Q37210833-557D33A0-4DF7-42DD-B441-F6930DB3185C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18612161
PubMed ID	18612161
published in	wds:Q37210833-C1889D7F-43E8-47DE-AE4E-CA5C121F8F86
published in	Journal of Clinical Oncology
issue	wds:Q37210833-177C404F-AE40-42FB-894F-C8D3ACAD7708
volume	wds:Q37210833-0606B514-75FD-40D5-A41A-21FE5AAD03D7
issue	20
volume	26
DOI	wds:Q37210833-4A454FF6-B1F8-4336-A1E9-0A6A000DCBAF
DOI	http://dx.doi.org/10.1200/JCO.2007.14.6423
DOI	10.1200/JCO.2007.14.6423
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37210833
is cites work of	Implication of human herpesviruses in oncogenesis through immune evasion and supression Immunotherapy of cancer in 2012. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells Modulation of T-cell activation by malignant melanoma initiating cells Antitumor immunity and cancer stem cells Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes Cytokines in cancer immunotherapy Antibody therapy of cancer Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study A new understanding in the epidemiology of melanoma Engineering dendritic cells to enhance cancer immunotherapy Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination Cancer immunotherapy: Progress and challenges in the clinical setting Cancer immunotherapy: accomplishments to date and future promise Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma. Immunotherapy for metastatic melanoma Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software